# Equivalence Study of Specificity of PPD

> **NCT01798095** · PHASE2 · UNKNOWN · sponsor: **JHP Pharmaceuticals LLC** · enrollment: 152 (estimated)

## Conditions studied

- Tuberculosis Infection

## Interventions

- **BIOLOGICAL:** Aplisol@ PPD material
- **BIOLOGICAL:** Reference Standard

## Key facts

- **NCT ID:** NCT01798095
- **Lead sponsor:** JHP Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798095, "Equivalence Study of Specificity of PPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01798095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*